# CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

> **NCT06652412** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 124 (estimated)

## Conditions studied

- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** Ultrafractionated RT and CGA Guided systemic treatment.
- **OTHER:** data prospectively collected
- **RADIATION:** Ultrafractionated Radiotherapy
- **DRUG:** Sintilimab
- **DRUG:** Fluorouracil
- **DRUG:** Raltitrexed
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan (CPT-11)

## Key facts

- **NCT ID:** NCT06652412
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11
- **Primary completion:** 2027-11
- **Final completion:** 2028-11
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06652412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06652412, "CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06652412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*